Publication | Open Access
LncRNA TROJAN promotes proliferation and resistance to CDK4/6 inhibitor via CDK2 transcriptional activation in ER+ breast cancer
87
Citations
33
References
2020
Year
TROJAN promotes ER+ breast cancer proliferation and is a potential target for reversing CDK4/6 inhibitor resistance.
| Year | Citations | |
|---|---|---|
Page 1
Page 1